Application 020248
- Type
- NDA
- Sponsor
- FRESENIUS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | INTRALIPID 20% | SOYBEAN OIL | INJECTABLE;INJECTION | 20% | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020248-001 | INTRALIPID 20% | SOYBEAN OIL | 20% | INJECTABLE / INJECTION | AP | RLD, RS | 1996-08-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N020248-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N020248-001 | INTRALIPID 20% | 20% | INJECTABLE / INJECTION | AP | RLD, RS | 1996-08-07 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N020248-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Intralipid | I.V. FAT EMULSION | Fresenius Kabi USA, LLC | bdcc364b-77b2-4939-8add-03e5396d46c2 | 2025-10-08 | Warnings, Adverse reactions | 020248 NDA020248 |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare Corporation | 55609586-f0b4-42e6-8dd9-cd090afb5dca | 2022-07-21 | Boxed warning, Adverse reactions | 020248 NDA020248 0338-0519 |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare Corporation | a69c82da-15ba-4d4d-8d7f-871dc3981eb8 | 2022-07-21 | Boxed warning, Adverse reactions | 0338-0519 |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare Corporation | cbd3396e-6b85-41bf-82d2-940beba86686 | 2019-01-09 | Boxed warning, Warnings, Adverse reactions | 020248 NDA020248 0338-0519 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0338-0519 | Intralipid | SOYBEAN OIL | Baxter Healthcare CORP | NDA | Current |
| 0338-0519 | Intralipid | I.V. Fat Emulsion | Baxter Healthcare Corporation | NDA | Current |
| 0338-0519 | Intralipid | I.V. Fat Emulsion | Baxter Healthcare Corporation | NDA | Current |
| 0338-0519 | Intralipid | I.V. Fat Emulsion | Baxter Healthcare Corporation | NDA | Current |
| 0338-0519 | Intralipid | SOYBEAN OIL | Baxter Healthcare Corpora | NDA | Current |